Emerson Reports Strong Q1 Underlying Orders, Exceeds Profitability Expectations, Updates 2026 Outlook
EMR sits 67% above its 52-week low of $90.055.
Summary
Emerson reported Q1 2026 results with strong underlying orders and better-than-expected profitability, while updating its full-year 2026 financial outlook and announcing a $1.0 billion share repurchase plan.
Key Events · Earnings and Guidance · EMR
-
Q1 2026 Financial Performance
Reported Q1 2026 GAAP EPS of $1.07 (up 5%) and Adjusted EPS of $1.46 (up 6%), with underlying orders growing 9% and net sales increasing 4%.
-
Profitability Exceeded Expectations
Management stated the company "met sales commitments and exceeded expectations for profitability," driven by robust demand in automation technology.
-
Cash Flow Decline
Operating cash flow decreased 10% to $699 million, and free cash flow decreased 13% to $602 million compared to the prior year.
-
Updated Full-Year 2026 Outlook
Provided revised guidance for fiscal 2026, including approximately 4% underlying sales growth and adjusted EPS between $6.40 and $6.55.
Analysis · EMR · Manufacturing
Emerson Electric Co. reported its first-quarter fiscal 2026 results, showcasing strong underlying orders growth and exceeding profitability expectations. Despite a decline in operating and free cash flow, the company delivered increased GAAP and Adjusted EPS. The updated full-year 2026 outlook provides revised expectations for sales, earnings, and cash flow, alongside a commitment to return capital through dividends and a $1.0 billion share repurchase program. Investors should monitor the company's ability to convert strong orders into improved cash flow in subsequent quarters.
How filings like this one have moved
In the 30 days to Oct 4, 2026, 29.2% of the 1581 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.60%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, EMR was trading at $150.35 on NYSE in the Manufacturing sector, with a market capitalization of approximately $85.4B. The 52-week trading range was $90.06 to $154.04. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.